Atlas Trials

Study of Evacetrapib (LY2484595) and Warfarin in Healthy Participants

Clinical trial NCT02161731 · COMPLETED

Trial details

NCT number
NCT02161731
Sponsor
Eli Lilly and Company
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy Volunteers
Start date
2014-06-01
Primary completion
2014-09-01
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.